Quintrio
Home

MEDICINAL CHEMICALS & BOTANICAL PRODUCTS

Canopy Growth Corporation Common Shares

CGC

Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.

Last trade $0.537
Day change -$0.009 (-1.65%)
Day range $0.533 – $0.584
Volume 1,728,084
Market cap $231M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$232.84M
Price / earnings
—
Price / book
0.48×
Price / sales
0.97×
EV / sales
0.68×
EV / EBITDA
-4.05×

Profitability

Earnings per share
-$0.40
Return on assets
-21.76%
Return on equity
-34.89%
Dividend yield
0%

Liquidity and leverage

Debt / equity
0.35×
Current ratio
3.04×
Quick ratio
2.39×
Cash ratio
2.02×

Cash flow

Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$59.3M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for CGC, quarterly periods
Line itemQ1 FY2027 Jun 30, 2026Q4 FY2026 Mar 31, 2026Q3 FY2026 Dec 31, 2025Q2 FY2026 Sep 30, 2025Q1 FY2026 Jun 30, 2025Q4 FY2025 Mar 31, 2025Q3 FY2025 Dec 31, 2024Q2 FY2025 Sep 30, 2024
Revenue$57.13M$58.48M$65.86M$59.61M$53.02M$53.73M$60.1M$54.67M
Cost of revenue$41.47M$43.89M$38.67M$32.16M$39.76M$37.6M$35.3M$30.42M
Gross profit$15.65M$14.59M$27.19M$27.45M$13.26M$16.13M$24.79M$24.25M
Selling, general and administrative$29.27M$29.52M$33.02M$27.51M$27.93M$13.41M$32.5M$34.71M
Research and development$0$0$0$0$0$0$0$0
Total operating expenses$29.27M$38.74M$44.57M$39.23M$27.93M$22.35M$40.5M$42.82M
Operating income-$13.62M-$24.15M-$17.38M-$11.78M-$14.68M-$6.22M-$15.7M-$18.56M
Interest expense-$8.92M$0$0$0-$7.16M$0$0$0
Income before taxes-$10.35M-$112.64M-$45.36M-$1.02M-$32.76M-$90.94M-$84.72M-$97.02M
Income taxes-$90.79K-$619.5K$268.11K$153.69K$213.87K$215.25K$220.2K$223.25K
Net income-$10.26M-$112.02M-$45.63M-$1.18M-$32.97M-$90.67M-$84.94M-$94.84M
Net income attributable to common shareholders-$10.26M-$112.02M-$45.63M-$1.18M-$32.97M-$90.67M-$84.94M-$94.84M
EBITDA-$6.55M-$18.18M-$10.7M-$5.3M-$7.57M$1.68M-$9.42M-$10.86M
Basic earnings per share-$0.02-$0.29-$0.13-$0.01-$0.18-$0.59-$0.77-$1.09
Diluted earnings per share-$0.02-$0.29-$0.13-$0.01-$0.18-$0.59-$0.77-$1.09

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
Zacks Investment Research

Investors Heavily Search Canopy Growth Corporation (CGC): Here is What You Need to Know

Canopy Growth Corporation (CGC) is receiving heavy investor attention, but the stock has underperformed significantly, declining 15.4% over the past month compared to the S&P 500's 2.4% decline. The company faces challenges with negative earnings estimates, a Zacks Rank #4 (Sell) rating, and premium valuation metrics relative to peers. While revenue is expected to grow modestly, earnings estimate revisions have been negative, suggesting the stock may underperform the broader market in the near term.

The Motley Fool

Which of These 5 Cannabis Stocks Has the Strongest Balance Sheet?

An analysis of five major cannabis stocks reveals significant differences in financial health. Cronos Group leads with approximately $841 million in cash and no significant debt, followed closely by SNDL, which is debt-free with positive free cash flow. Tilray and Canopy Growth continue to struggle with debt and negative cash flow despite some revenue growth, while Aurora Cannabis has a smaller liquidity cushion. A strong balance sheet provides financial flexibility but doesn't guarantee profitability or shareholder returns.

Zacks Investment Research

Canopy Growth Corporation (CGC) Reports Q2 Loss, Lags Revenue Estimates

Canopy Growth reported a Q2 loss of $0.07 per share, significantly worse than the consensus estimate of $0.02 loss, representing a -250% earnings surprise. Revenue of $58.15 million missed estimates by 1.63%, though it improved from $48.42 million year-ago. The stock has declined 40.7% year-to-date and carries a Zacks Rank #3 (Hold) rating with mixed estimate revisions.

Zacks Investment Research

Concentra Group (CON) Tops Q3 Earnings and Revenue Estimates

Concentra Group (CON) reported quarterly earnings of $0.52 per share, beating consensus estimates of $0.45 and surpassing revenue expectations with $622.12 million. The company has outperformed the market by 121.3% year-to-date and received a Zacks Rank #2 (Buy) rating. Canopy Growth Corporation (CGC) is expected to report a quarterly loss of $0.02 per share with revenues projected at $59.12 million.

The Motley Fool

Canopy Growth vs. Tilray Brands: Quarterly Revenue Scale and Consistency in Cannabis

Tilray Brands maintains a 4x revenue advantage over Canopy Growth, consistently generating $200+ million quarterly revenue compared to Canopy's $45-73 million. While both companies show year-over-year growth when comparing comparable quarters, Tilray demonstrates more stable and higher revenue levels. Canopy's latest Q4 2025 quarter ($73.3M) suggests potential momentum, but the revenue gap remains substantial.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

Ex-dividendAmount / sharePay dateType
Aug 1, 2007$2.40Aug 15, 2007unknown
Apr 26, 2007$2.40May 15, 2007recurring
Jan 29, 2007$2.40Feb 15, 2007recurring
Oct 27, 2006$2.40Nov 15, 2006recurring
Jul 27, 2006$2.40Aug 15, 2006recurring

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
Dec 20, 20231-for-10reverse split